When it comes to diagnosing prostate cancer, accuracy matters. MRI/ultrasound fusion biopsy combines advanced imaging with real-time guidance to precisely target suspicious areas—helping detect significant cancer while avoiding unnecessary treatment.
A prostate MRI is often recommended before biopsy, especially if you have:
• Even if an MRI appears normal, a biopsy may still be necessary in some cases.
Without MRI guidance, biopsies are typically performed using random sampling—which can miss important cancer.
With MRI:
Bottom line: We’re not guessing—we’re aiming.
We typically perform biopsies using a transperineal approach, which offers:
For select patients, an in-office biopsy with local anesthesia is also available.
Most patients experience minimal side effects, which may include:
Serious complications are exceedingly rare, and there is no evidence that biopsy spreads cancer.
Once results are available:
Using MRI-guided biopsy significantly improves confidence—whether cancer is found or not.
The same MRI technology is used to plan advanced, targeted treatments such as:
Follow-up MRI (typically at 6–12 months) helps confirm treatment success.
Dr. Jurige is among the earliest adopters of MRI fusion biopsy and is recognized for training other physicians in this advanced technique.
If you’ve been told you need a prostate biopsy—or want a more precise evaluation—MRI-guided biopsy may be the best place to start.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.